Methods and analysis 53 We will search Medline OVID, Embase OVID, CINAHL and PsycINFO with no date restriction, using a 54 pilot-tested search strategy of terms related to vaccination; knowledge, attitudes, beliefs, trust, 55 acceptance and decision-making; and measurement, psychometric testing or validation. This search 56 will be supplemented with hand searching and expert consultation. We will include studies that 57 describe instrument development, adaptation or testing and include evaluation of at least one 58 measurement property (e.g. content, criterion, or construct validity; test-retest reliability; internal 59 consistency; sensitivity; responsiveness). Instruments will be included if they measure a vaccination-60 related psychosocial factor in any population. All studies will be screened by one reviewer, with a 61 sample dual-screened to confirm accuracy. Disagreements will be resolved with a third reviewer. Outbreaks of vaccine-preventable diseases are a growing international crisis, with worldwide 80 measles cases increasing by 300% from 2018 to 2019 (1). Under-and non-vaccination is driven by 81 both barriers to access and vaccine hesitancy, which the World Health Organization has named as a 82 threat to global health (2, 3). Now, more than ever, there is an urgent global focus on the 83 development, implementation and evaluation of interventions and policies to increase vaccine 84 uptake.
85
Vaccine uptake -like other health behaviours -is shaped by communication, interaction and 86 psychosocial factors (4, 5) . The language around these factors can vary depending on the context or 87 discipline. Building on our earlier taxonomic work in this area, we consider 'psychosocial factors' to 88 include knowledge, attitudes, beliefs, values, self-efficacy, vaccine confidence, trust and aspects of 89 individual decision-making (4). We also use the term 'factors' here, though they may be referred to 90 as 'constructs' in a psychometric context, or 'outcomes' in an intervention evaluation.
91
A variety of theoretical models aim to describe the way in which these psychosocial subjective norms and knowledge (6) (7) (8) . Models of shared decision-making also suggest that health 96 behaviour can be shaped by the decision-making experience itself, through quantifiable factors such 97 as anticipated regret, decisional conflict or satisfaction with the process (4). For vaccination 98 specifically, additional factors like confidence, trust and values have been shown to be linked to 99 behaviour (9-11).
100
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152
Studies will be excluded if the instrument is used only as an outcome measure or to collect 153 observational data, with no evaluation of any measurement properties. Because face validity is a 154 subjective judgment made by individuals with no expertise in the subject area, studies that measure 155 or report only face validity, with no other measurement properties addressed, will also be excluded 156 (22).
157
Search strategy 158 We will search the following electronic databases: Medline OVID, Embase OVID, CINAHL and 159 PsycINFO. The search strategy includes index and text words related to vaccination or immunisation; 160 knowledge, attitudes, acceptance and decision-making; and measurement, psychometric testing or 161 validation. Using a set of approximately ten studies we knew to be relevant, we pilot tested and 162 refined the search strategy to ensure it will be both sensitive and focused. The full search strategy is 163 included as an appendix (Additional File 1).
164
We will also hand search the reference lists of relevant studies and we will consult with experts in 165 the field to identify any additional references or links to instruments.
166

Study selection
167 Search results will be loaded into Endnote X8 (Clarivate Analytics 2016) and duplicates will be 168 removed. Studies will be screened first by title and abstract, with potentially eligible studies 169 screened by full text. One author (JK) will conduct the primary screening. A second author will screen 170 a sample of the results to compare and confirm the screening approach. Other authors will be asked 171 to provide input where screening decisions are not straightforward. 197 In keeping with standard scoping review methodology, our aim is to identify and describe all 198 available instruments that have undertaken some degree of validation, regardless of the 199 methodological quality of the studies or the validation techniques applied (23). Therefore, while we 200 will collect information about which measurement properties the authors report having evaluated, 201 we will not formally assess their methodological quality.
202
Data synthesis strategy 203
The data will be synthesised narratively and through summary tables which will chart the 204 characteristics of the instruments for ease of comparison. The synthesis will provide an overview of 205 the instruments measuring each factor, with specific sub-analyses organised by relevant features 206 such as date and/or location of development or validation; measurement properties evaluated; and 207 population of intended use. Comparative tables will be used where relevant. If many instruments 208 measuring the same factors are identified, their key differences and similarities will be explored with 209 more detailed analysis. To identify gaps, i.e. factors that are not measured in any identified 210 instruments, the instruments will be mapped against a taxonomy of outcomes relevant to 211 vaccination communication (4).
212
Patient and public involvement 213
The development of this scoping review protocol did not involve patients or the public.
214
Ethics and dissemination 215 This scoping review is intended to help researchers, policymakers, vaccination program officials and 216 other stakeholders identify appropriate, fit-for-purpose instruments to gather population data and 217 evaluate vaccine promotion strategies. Healthcare practitioners may also find useful instruments to 
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171
Using these relevant studies, we pilot tested and refined the search strategy to ensure it will be both 172 sensitive and focused. The full search strategy is included as an appendix (Additional File 1).
173
We will also review the reference lists of relevant studies and consult experts in the field, identified 174 through the authors' international networks, to identify any additional references or links to 175 instruments. Any uncertainties, e.g. about the nature of measurement property assessment, will be raised with 206 the other authors for discussion and resolution.
207
In keeping with standard scoping review methodology, we will assess the degree of validation for 208 each tool by reporting which measurement properties have been evaluated, but will not appraise 209 the quality of the specific validation methods used (23, 25) .
210
Data synthesis strategy 211
The data will be synthesised narratively and through summary tables which will chart the 212 characteristics of the instruments for ease of comparison. The synthesis will provide an overview of 213 the instruments measuring each factor, with specific sub-analyses organised by relevant features 214 such as date and/or location of development or validation and population of intended use.
215
Comparative tables will be used where relevant. For each tool, we will summarise the measurement 216 properties evaluated using tables similar to the Cochrane risk of bias summary figures for 217 intervention reviews (26). If many instruments measuring the same factors are identified, their key 218 differences and similarities will be explored with more detailed analysis. To identify gaps, i.e. factors 219 that are not measured in any identified instruments, the instruments will be mapped against a 220 taxonomy of outcomes relevant to vaccination communication (4).
221
Patient and public involvement 222
The development of this scoping review protocol did not involve patients or the public. 
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